Sundaresh has over 25 years of experience in leadership roles across various organizations in Finance, Business Development, Management, Regulatory Compliance. He has been associated with the life sciences industry for more than two decades. He has an excellent knowledge in Disruptive Technology development and marketing. Sundaresh is instrumental in setting up and building global clients and partnerships with key customers for TheraIndx Lifesciences; a Drug Discovery and Development Contract Research Organisation recognized globally.
Co-Founder and CSO
Ramesh Jayaraman, Founder and Director, has over 26 years of experience in Drug Discovery and Development in critical therapeutic areas like oncology and infection. His core expertise is in Biochemistry, Pharmacokinetics and Pharmacodynamics. He has played a pivotal role in global drug discovery programs at organizations like AstraZeneca and S*Bio. As a Senior Scientist and Team Leader in S*BIO Pte Ltd Singapore, he was responsible for preclinical development, PK, ADME, and toxicology for three small molecule targeted anticancer clinical development candidates - Pacritinib in Phase III trials for Myelofibrosis, Pracinostat in Phase II trials for solid tumors and TG02 in Phase II trials for lymphoma. Ramesh has been at the core in anti-tuberculosis drug discovery during his stint as Research Scientist and Team Leader at AstraZeneca India Pvt Ltd. He is an expert in PK, PD and PK/PD, managing lead identification and optimization projects, modeling and simulation. He has 18 publications including a book chapter in reputed International Journals. Ramesh heads scientific operations at OncoDynamiX.
Head of Cancer biology
Priyanka is a passionate cancer biologist with experience in research and development, and clinical translations in cancer. Expert in biochemical pathways of cancer with deep understanding of cancer pathway networks linked to carcinogenesis.
Head - Cancer Biology
Priyanka Bhargav is an expert in biochemical pathways in cancer cells with deep understanding of pathway networks linked to carcinogenesis and mechanism of action of anti-cancer drugs.
Dr. Sachin Jadav
Director Clinical Research
Dr Sachin Jadhav, Group Head, Hematology and Bone Marrow Transplant, HCG Group of Hospitals
Dr. Felix Garzon
Founder and CEO of FTG Bio USA
Dr. Felix Garzon , Founder and CEO of FTG Bio USA. Expert in Onco-Hematology Drug Development, USA
Member of Board of Directors
Dr Surender M Kharbanda, President, Founder and CSO of Genus Oncology, Boston and Senior Scientist at Dana Farber Cancer Institute, Harvard Medical School
Member of Board of Directors
Dr Satish Kitambi, Scientist at Karolinska Institute, Sweden and Chief Operating Officer (COO) of K-Life Solutions
Vinay Sheel Bansal
Member of Board of Directors
Prof (Dr) Vinay Sheel Bansal, CEO of K-Life Solutions, Hyderabad, has 40 years of rich experience of the Academia and New Drug Discovery, both in in the USA (Merck & Co., USA) and India (Ranbaxy/Sankyo/Diachii, Japan). He is a Sr. Adviser/ Consultant to several Indian & US companies to provide intellectual in depth scientific/business development knowledge through his vast connections across India & USA. He is also Sr. Adjunct Professor at VIT University, Vellore, one of the top premier University in India. Recently he has been appointed as Professor in Institute of Healthcare Education and Translational Sciences – IHETS), Hyderabad). He is a highly enthusiastic individual with hands-on teaching experience with positive attitude and in short span of time, he has contributed to the success of VIT University and Hylasco/Crl, Boston, USA. He has got a natural flair for assisting students in meeting their educational cum research goals and career aspirations. His ability for critical thinking while managing several professional and social causes at the same time is an asset for everyone. Besides, he takes pride in learning new things both scientifically as well as non-scientific aspects. As an astute professional offering of 40 years of rich & comprehensive experiences in achieving results in a highly competitive environment of the Drug Discovery where success rate is Right now, he is highly focused in creating an ecosystem of the talented scientists to discover novel Cancer Drugs by using ancient Indian herbal anti-cancer plants and other valuable Herbal Products for the common poor Indians under the “Make in India” program by using the latest advance technologies.
Director Clinical Management
Dipanjan Chakraborty, has been in the Biotech and Life Sciences sector for more than two decades. He has expertise in Molecular diagnostics, Contract Research, Clinical Trials, Clinical data management, Drug discovery informatics, drug development and product development. He has played a leadership role in Techno commercial business development and concept creation and evidence generation in critical care infections. Dipanjan is passionate about launching disruptive innovations. He has many peer reviewed publications.
Srinivasan V K
Srinivasan V K, has more than 25 years of diversified experience in Business Development, Sales and marketing in pharmaceutical and Diagnostic Industry. He is an expert in the craft of enabling start-ups hit the market with well-tuned Go-To-Market strategy. He was part of launching new products, technologies across categories like Anti-Infectives, Oncology, Neutraceuticals, Cardio-Diabetics and Molecular Diagnostics. He has been instrumental in creating a “blue-ocean” in the field of molecular diagnostics for critical care infections.
Co-Founder & CEO of Gotown, Inc.
Tim is the CEO and a co-founder of Gotown, a global business accelerator that guides tech start-ups to genuine success. He is an expert at driving business growth for large and small companies. He's served many of the world's largest and most successful companies, including AT&T, Citibank and General Motors and has 30+ years' experience in executive leadership, business development, strategic planning, and marketing. He's also successfully started and built four professional services and technology businesses to serve these highly respected companies.
Dr. Gareth Morris-Stiff
Surgeon with 28 years of postgraduate experience and specific expertise in managing cancers of the liver, pancreas, gallbladder and biliary tree. Has a decade of experience as a key opinion leader in pancreatic cancer and subject matter expert in exocrine pancreatic insufficiency. Has extensive Pharma experience with c-suite positions in 5 companies, together with numerous advisory board appointments in biopharma and biotech companies.
Harsh Muthal is an Investor, Entrepreneur and experienced Business Manager. He has over 35 years of ‘C’ level experience with global multinationals like UniLever, Motorola and IBM. In the late eighties, Harsh was instrumental in establishing Motorola operations in India, China, and the Indo-Pacific. He won the Motorola CEO gold award for an innovative marketing campaign to introduce usefulness of wireless technology to policy makers in developing countries. At IBM he led the Telecom Industry Sector as the Industry Leader. Harsh currently owns a boutique consulting firm out of Chicago. His firm is focused on Investment Banking, M&A advisory and Strategy Consulting.
Dr Jayanti Thumsi
Dr Jayanti Thumsi is currently working as a ‘Lead Surgeon-Breast Oncology’ at Apollo Hospital, Bannerghatta road, Bangalore, India.
Dr Jayanti Thumsi has graduated and completed her MS in General Surgery from Grant Medical College, JJ Hospital, Mumbai. She has undergone training in Breast Oncology at Tata Memorial Hospital, Mumbai. She has been practising Breast Oncology in Bangalore for 21 years and has a vast experience. She has performed more than 3500 breast surgeries and 2500 other surgeries so far, with an expertise in Breast conservation and Breast Reconstruction surgeries.
She has keen interest in bringing about awareness in women about Breast cancer and has been very active in conducting more than 258 awareness programs and has educated 4,58,000 women so far. She has done a number of TV shows, Radio programs, written newspaper articles, YouTube videos, Facebook live programs, etc.
She has authored a book ‘Lump to Laughter’ which highlights the emotional journey of women going through breast cancer treatment with medically validated information. This book is already in its third edition.
She has been honoured with
Woman Achiever of Karnataka 2019 by VRL group, Vijayvani and Digvijay TV.
Kengal Hanumanthaiah State Award 2019 for her work in the field of Breast Oncology and her contribution to the society.
Chankya National Award – Jury Special Award for Medical Inspiration by the Public Relation Council of India & World Communicators Council on 6th March 2020
She is the founder member and managing director of CREST Foundation, which is a NGO working on reducing the burden of cancer in our society. Under her leadership CREST Foundation had collaborated and organised ‘The World’s Largest campaign for Breast self-examination’ in which 2332 women were taught Breast Self - Examination in a single day. This event has a world record & has been recognised by Limca book of records. CREST Foundation has sponsored education for 3 deserving meritorious but under privileged students for completing MBBS. Dr Jayanti has published many papers in various national and international journals. She has been an invited speaker in many national and international conferences. She is also involved in many research activities and clinical trials.